8-K: Teledyne to Acquire Varex Imaging for $1.1 Billion

Teledyne Technologies Incorporated announced a definitive agreement to acquire Varex Imaging Corporation for $18.90 per share in cash, valuing the deal at approximately $1.1 billion.

Summary

• Varex Imaging Corporation has entered into a definitive agreement to be acquired by Teledyne Technologies Incorporated.
• The acquisition price is $18.90 per share in cash, resulting in an aggregate transaction value of approximately $1.1 billion, considering Varex's equity awards and net debt as of April 3, 2026.
• The transaction has been unanimously approved by the Boards of Directors of both Teledyne and Varex.
• Varex is a pioneer in X-ray sources and digital X-ray detectors, also providing related components and software.
• Teledyne has existing, complementary businesses in digital imaging and electronics, with minimal product overlap with Varex.
• The acquisition is expected to close in early 2027, subject to customary closing conditions, including regulatory approvals and Varex stockholder approval.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive development, indicating a strategic acquisition at a premium price, though subject to closing conditions.

Positives

• Varex shareholders will receive a substantial premium of $18.90 per share in cash.
• The acquisition offers exciting opportunities for Varex's customers and employees.
• Teledyne's acquisition of Varex is seen as a strategic fit, with complementary technologies and minimal product overlap.
• Teledyne's resources are expected to help accelerate Varex's adoption of advanced imaging solutions and product development.
• The transaction is not subject to a financing condition for Teledyne.

Negatives

• The transaction is subject to regulatory approvals and Varex stockholder approval, which could delay or prevent closing.
• There is a risk of potential adverse reactions or changes to business relationships, operating results, and the business generally due to the announcement and pendency of the transaction.
• There is a risk of litigation relating to the proposed transaction.
• There is a risk of inability to retain key personnel, management, or customers.
• There is a risk of diminished productivity due to the impact of the transaction on employees, management, customers, and business partners.
• Management's attention may be diverted from ongoing business operations.
• There is a risk of unexpected delays, costs, charges, fees, or expenses.
• There is a risk that the stock price may fluctuate and decline significantly if the transaction is not completed.

Risks

• Failure to obtain required regulatory approvals or expiration of applicable waiting periods, including under the Hart-Scott-Rodino Antitrust Improvements Act.
• Failure to obtain Varex stockholder approval.
• The occurrence of any event, change, or circumstance that could give rise to the termination of the merger agreement, potentially requiring Varex to pay a termination fee of $25.3 million.
• Potential adverse reactions or changes to business relationships, operating results, and the business generally resulting from the announcement, pendency, or inability to complete the transaction.
• Inability to retain key personnel, management, or customers, or potential diminished productivity due to the impact of the transaction.
• Risks related to diverting management's attention from ongoing business operations.
• Unexpected delays, costs, charges, fees, or expenses resulting from the transaction.
• The risk that the price of Varex's common stock may fluctuate during the pendency of the transaction and may decline significantly if the transaction is not completed.

Future Outlook

The transaction is expected to close in early 2027, subject to customary closing conditions, including regulatory approvals and Varex stockholder approval. Teledyne expects to utilize borrowings under its existing credit facility to finance the transactions, and the availability of such financing is not a condition to closing.

Management Comments

• "For decades, Varex has pioneered the development of X-ray sources and digital X-ray detectors, and also provides high-voltage interconnects and imaging software to global OEM manufacturers."
• "Nevertheless, while Teledyne and Varex serve similar customers with related technologies, our products are uniquely complementary with minimal overlap."
• "Joining Teledyne marks an exciting new chapter for Varex. This transaction provides a substantial premium for our shareholders and exciting opportunities for our customers and employees across the medical and industrial markets we serve."
• "Our X-ray technologies fit naturally alongside Teledyne's product portfolio, and its resources will help us accelerate adoption of our advanced imaging solutions, and development of the next generation of products."

Industry Context

StockSavvy.ai notes that this acquisition aligns with industry consolidation trends, particularly in the specialized imaging and component manufacturing sectors. Teledyne's expansion into Varex's niche areas like photon counting detectors and high-radiation environment detectors suggests a strategic move to broaden its technological capabilities and market reach within both medical and industrial imaging.

Management Changes

Legal Proceedings

• There are no pending or threatened actions against Varex or its subsidiaries that would reasonably be expected to prevent or materially impair the ability to perform its obligations under the merger agreement or consummate the transactions, or that would reasonably be expected to have a Company Material Adverse Effect.

Stakeholder Impact

• Shareholders: Will receive $18.90 per share in cash, representing a substantial premium.
• Employees: Executive compensation (options, RSUs, PSUs) will accelerate and vest. Continuing employees will receive comparable salary, incentive, and benefits for at least one year post-merger.
• Customers: Will benefit from Teledyne's resources to accelerate adoption of Varex's advanced imaging solutions and product development.
• Suppliers: No specific impact mentioned, but business continuity is implied.

Next Steps

• Varex stockholders will be asked to adopt the Merger Agreement at a special meeting.
• Varex will prepare and file a proxy statement with the SEC within 30 days of the merger agreement signing.
• The definitive proxy statement will be mailed to stockholders after SEC confirmation.
• The transaction is subject to regulatory approvals and expiration of applicable waiting periods.
• The merger is expected to close in early 2027.

Key Dates

Recommendation

The acquisition at a premium is positive for Varex shareholders, but the deal is contingent on closing conditions. For existing Varex shareholders, holding is appropriate to await the closing or potential alternative offers. For potential investors, the current price likely reflects the acquisition offer, making it less attractive for a new 'buy' recommendation without further market shifts or a significant discount.

Keywords

merger, acquisition, Teledyne Technologies, Varex Imaging, X-ray, imaging components, digital detectors, medical imaging